Discover how early diagnosis and enzyme replacement therapy helped Prajwal overcome Gauchers disease and shine in cricket ...

SHANGHAI, CHINA / ACCESS Newswire / July 22, 2025 / Lingyi Biotech , a clinical-stage biotechnology company specializing in ...

The sector is expected to hit $553.8m by 2034. The growing integration of genetic testing into national healthcare frameworks ...

Cerner and the International Gaucher Alliance, announced the opening of the Gardian (Gaucher Registry for Development Innovation and Analysis of Neuronopathic Disease) registry.

Gaucher disease types 2 and 3 are neuronopathic diseases that cause early onset brain damage, per the National Gaucher Foundation. There is currently no treatment for the fatal disease. 6.

People with the rare inherited metabolic disorder Gaucher disease have a deficiency in the lipid-digesting glucocerebrosidase enzyme, which causes the accumulation of harmful levels of glucolipids in ...

Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for FLT201, its Clinical-Stage Gene Therapy Candidate in Gaucher Disease ...

Some of the newly identified risk loci are thought to be involved with Gaucher's disease, and in regulating inflammation and dopamine as well as α-synuclein, a protein that accumulates in the ...